The Metacognition Assessment Scale (MAS-A): Results of a pilot study applying a German translation to individuals with schizophrenia spectrum disorders.
Metacognition, the capacity 'to think about thinking' and thus to reflect and to master interpersonal problems on a mentalistic basis, is often impaired among patients with schizophrenia spectrum disorders and has been suggested as a potential treatment target. However, little is known about the reliability of its measurement and links with related phenomena. The aim of this study was to validate a German translation of the Metacognition Assessment Scale (MAS-A) as a measure to assess metacognition from free narratives of patients' personally relevant episodes and relationships.



MAS-A was applied to narratives of 22 individuals with schizophrenia spectrum disorders together with self-ratings and behavioural tests of metacognitive and related functions such as mentalizing and emotional awareness. Multi-level modelling allowed to calculate inter-rater reliability (IRR) and inter-rater agreement (IRA) and to include test results as level-2 predictors of the aggregated scorings on the MAS-A subscales in order to explore convergent validity. After considering neurocognition and symptom scores as further predictors, aggregated scorings were correlated with psychosocial functioning.



There were high IRRs and IRAs all over the ratings. None of the related measures accounted for variance in MAS-A scorings, indicating the existence of separable, non-overlapping constructs. Verbal memory and positive symptoms were significant predictors for MAS-A subscales. MAS-A, but no other measure, displayed significant associations with psychosocial functioning.



MAS-A is a reliable expert rating to assess metacognition from patients' free narratives. Considering the link to psychosocial functioning, MAS-A appears to be a promising tool for the evaluation of metacognition.



MAS-A is a reliable tool to evaluate metacognitive function from narratives about emotionally relevant topics and meaningful relationships. Metacognition appears separate from neighbouring constructs such as mentalizing, ToM, or emotional awareness. MAS-A scales are significantly predicted by verbal memory and positive symptoms. Only MAS-A scales display significant associations with psychosocial functioning, and it thus is a promising tool to evaluate metacognition in psychotherapy research.
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.
Anna-Lena
AL
Bröcker
International Psychoanalytic University Berlin (IPU), Berlin, Germany.
Samuel
S
Bayer
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.
Frauke
F
Stuke
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.|Department Psychology, Medical School Brandenburg Theodor Fontane, Am Alten Gymnasium 1-3, 16186, Neuruppin, Germany.
Patrick
P
Giemsa
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.
Andreas
A
Heinz
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.
Felix
F
Bermpohl
Roudebush VA Medical Center, Indianapolis, Indiana, USA.|Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Paul H
PH
Lysaker
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Germany.
Christiane
C
Montag
D000328:Adult; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D000067489:Metacognition / Q000502:physiology*; D008875:Middle Aged; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales / Q000592:standards*; D011594:Psychometrics / Q000379:methods*; D015203:Reproducibility of Results; D012559:Schizophrenia / Q000175:diagnosis*; D014175:Translating; D055815:Young Adult
Metacognition Assessment Scale-abbreviated; mentalizing; metacognition; perspective-taking; psychosis; psychotherapy; schizophrenia; social cognition; theory of mind